Evidence map›Paper›PMID 41865196›Full record

ArticleApplied microbiology and biotechnology2026

Hyaluronic acid degradation by Purpureocillium lilacinum: biochemical and transcriptomic insights.

Marina Minguet-Lobato, David Fernández-Polo, Fadia V Cervantes, Francisco J Plou, María Fernández-Lobato

Abstract read
In one paragraph

Article in Applied microbiology and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Marina Minguet-LobatoInstituto de Catalisis y Petroleoquimica (ICP-CSIC), 28049, Madrid, Spain. m.minguet@csic.es.ORCID http://orcid.org/0000-0001-8366-132X
David Fernández-PoloInstituto de Catalisis y Petroleoquimica (ICP-CSIC), 28049, Madrid, Spain.
Fadia V CervantesInstituto de Catalisis y Petroleoquimica (ICP-CSIC), 28049, Madrid, Spain.ORCID http://orcid.org/0000-0001-8844-8392
Francisco J PlouInstituto de Catalisis y Petroleoquimica (ICP-CSIC), 28049, Madrid, Spain.ORCID http://orcid.org/0000-0003-0831-893X
María Fernández-LobatoCentro e Instituto de Biología Molecular Severo Ochoa (CBM; CSIC-UAM), Department of Molecular Biology, Faculty of Sciences, Universidad Autónoma de Madrid, 28049, Madrid, Spain.ORCID http://orcid.org/0000-0003-0778-7443

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Enzymatic depolymerization of hyaluronic acid into well-defined oligosaccharides offers a sustainable alternative to chemical methods, providing precise control over product size and functionality. Yet, fungal enzymes capable of this transformation remain largely unexplored, despite fungi being prolific producers of carbohydrate-active enzymes through their complex secretomes. Here, we report the extracellular degradation of high molecular weight hyaluronic acid by the filamentous fungus Purpureocillium lilacinum. Hyaluronan depolymerization was monitored directly in culture supernatants, revealing the progressive accumulation of hyaluronan fragments and oligosaccharides with varying degrees of polymerization. Chromatographic time-resolved analyses showed the sequential appearance of long and short fragments, while mass spectrometric analysis demonstrated a complex product profile composed of even-numbered saturated and both even- and rare odd-numbered unsaturated species. This pattern differs from the uniform profiles typically generated by canonical hyaluronidases, suggesting a non-canonical degradation mechanism. Comparative cultivation of different Purpureocillium species showed that this activity is restricted to P. lilacinum among the species tested. To explore the genetic basis of this phenotype, a de novo transcriptome was assembled and functionally annotated. Although numerous carbohydrate-active enzymes were identified, none of the secreted candidates could be confidently assigned to known canonical hyaluronidase families. In particular, polysaccharide lyases associated with β-elimination mechanisms were not predicted to be secreted, and only a small fraction of glycoside hydrolases from families previously linked to hyaluronan degradation were extracellular. Together, our results establish P. lilacinum as a novel fungal system capable of extracellular hyaluronic acid degradation and support the existence of a non-canonical, potentially multienzymatic pathway. This work expands current knowledge of fungal glycosaminoglycan metabolism and highlights filamentous fungi as an underexplored source of hyaluronan-processing activities with biotechnological potential. KEY POINTS: • Purpureocillium lilacinum is a new hyaluronic acid degrader • Degradation yields diverse saturated and unsaturated hyaluronan oligosaccharides • Transcriptomics suggests a non-canonical, multienzymatic degradation system.

Indexed as

Hyaluronic AcidHypocrealesTranscriptomeFungal ProteinsGene Expression ProfilingHyaluronoglucosaminidaseMolecular WeightOligosaccharidesPolysaccharide-LyasesFungal ProteinsHyaluronic AcidHyaluronoglucosaminidaseOligosaccharidesPolysaccharide-LyasesCarbohydrate-active enzymesHyaluronan oligosaccharidesHyaluronic acidPurpureocillium lilacinum

Identifiers

PMID41865196
PMCPMC13009009

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.